CLINICAL AND IMMUNOLOGICAL EFFECT OF PNEUMOCOCCAL CONJUGATED VACCINES IN IMMUNOCOMPROMISED PATIENTS
Invasive pneumococcal infection is the most frequent cause of death in patients with immunodeficiences. The antibiotics used previously for prevention purposes are not efficient enough due to the developing antibiotic resistance. Polysaccharide pneumococcal vaccines create short-lived immunity. The...
Saved in:
| Main Authors: | A.A. Tarasova, M.P. Kostinov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2010-09-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1091 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity and Safety of 13-valent Conjugated Pneumococcal Vaccine in Patients with Rheumatoid Arthritis
by: B. T. Batozhargalova, et al.
Published: (2024-03-01) -
RECOMMENDATION ON THE 7–VALENT PNEUMOCOCCAL CONJUGATED VACCINE AMONG CHILDREN
by: M.V. Fedoseenko, et al.
Published: (2009-06-01) -
Indirect effect and pneumococcal conjugate vaccines
by: L. Temimi
Published: (2009-10-01) -
Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma
by: I. O. Stoma
Published: (2021-01-01) -
Pneumococcal Vaccine in Adults with Bronchopulmonary Pathology: from Prevention to Treatment
by: A. M. Kostinov, et al.
Published: (2023-07-01)